C12N 2800/101
For bacteria
Official title: for bacteria
C12N2800/101 (For bacteria) appears on 137 US grants and 451 published applications in this corpus.
Search patents in C12N- Granted patents
- 137
- Published applications
- 451
- Assignees
- 288
- Inventors
- 1,370
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 2 | 2 |
| 2013 | 2 | 0 |
| 2014 | 2 | 3 |
| 2015 | 0 | 2 |
| 2016 | 0 | 7 |
| 2017 | 3 | 5 |
| 2018 | 3 | 10 |
| 2019 | 3 | 13 |
| 2020 | 4 | 16 |
| 2021 | 4 | 14 |
| 2022 | 6 | 89 |
| 2023 | 11 | 86 |
| 2024 | 26 | 78 |
| 2025 | 32 | 61 |
| 2026 | 37 | 56 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Ketoreductase mutant and method for producing chiral alcohol29 Sep 2026US 12,747,460 B2Asymchem Laboratories (Fuxin) Co., Ltd.
- Method of preparing circular permutation-based functional recombinant human-derived fibroblast growth factor 7 and use thereof15 Sep 2026US 12,735,465 B2Industry Foundation of Chonnam National University
- Engineered strains of Corynebacteria15 Sep 2026US 12,735,730 B2
- Enumeration of genetically engineered microorganisms by live cell counting techniques1 Sep 2026US 12,721,882 B2Synlogic Operating Company, Inc.
- Phage-resistant microorganisms1 Sep 2026US 12,723,231 B2Innovacion Y Desarrollo De Energia Alfa Sustentable S.A. De C.V.
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- Production of carbon compounds1 Oct 2026US 2026/0297505 A1
- Polynucleotide molecule comprising poly(a) and use thereof24 Sep 2026US 2026/0286369 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- Phage defence genes for starter strains17 Sep 2026US 2026/0275363 A1Dsm IP Assets B.V.
- Microbial strain expressing an invertase/sucrose hydrolase10 Sep 2026US 2026/0265679 A1Dsm IP Assets B.V.
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation156US 9,822,372 B2Massachusetts Institute of Technology · 2017
- CRISPR-Cas component systems, methods and compositions for sequence manipulation135US 9,840,713 B2Massachusetts Institute of Technology · 2017
- Negative selection and stringency modulation in continuous evolution systems64US 10,179,911 B2President and Fellows of Harvard College · 2019